Skip to content
★ Sign in to follow
SH

Seth Hetherington V

Executive
Genocea Biosciences, Inc.Inhibitex IncIcagen, Inc.
Total declarations
27
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€62k

Latest filing published 09 Nov 2016 for Genocea Biosciences, INC., €9,166.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Seth Hetherington V: trading record in brief

Seth Hetherington V discloses dealings in 3 companies, chiefly Icagen, Inc., Genocea Biosciences, Inc. and Inhibitex Inc. We count 27 filings; the first trade dates from 10 January 2006 and the latest from 9 November 2016.

No open-market purchase appears, only 1 sale worth €62k. The rest of the record consists of 21 share grants and 5 option exercises.

Most recently, on 9 November 2016, the filings show an option exercise worth €9,166 in Genocea Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Seth Hetherington V

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations